Safety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique : a double blind randomised controlled phase I/IIb trial. CommentaryEPSTEIN, Judith E; APONTE, John J; LEACH, Amanda et al.Lancet (British edition). 2007, Vol 370, Num 9598, issn 0140-6736, 1523-1524, 1543-1551 [11 p.]Article

Evaluation of the Safety and Immunogenicity of the RTS,S/AS01_E Malaria Candidate Vaccine When Integrated in the Expanded Program of ImmunizationAGNANDJI, Selidji T; ASANTE, Kwaku Poku; CHIKAWE, Maria et al.The Journal of infectious diseases. 2010, Vol 202, Num 7, pp 1076-1087, issn 0022-1899, 12 p.Article

Efficacy of RTS,S/AS01E Vaccine against Malaria in Children 5 to 17 Months of AgeBEJON, Philip; LUSINGU, John; DEMOITIE, Marie-Ange et al.The New England journal of medicine. 2008, Vol 359, Num 24, pp 2521-2532, issn 0028-4793, 12 p.Article

Effect of the Pre-erythrocytic Candidate Malaria Vaccine RTS,S/AS01_E on Blood Stage Immunity in Young ChildrenBEJON, Philip; COOK, Jackie; DUTTA, Sheetij et al.The Journal of infectious diseases. 2011, Vol 204, Num 1, pp 9-18, issn 0022-1899, 10 p.Article

Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5-17 months in Kenya and Tanzania: a randomised controlled trialOLOTU, Ally; LUSINGU, John; VANSADIA, Preeti et al.Lancet. Infectious diseases (print). 2011, Vol 11, Num 2, pp 102-109, issn 1473-3099, 8 p.Article

Safety and efficacy of the RTS,S/AS01_E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trialKWAKU POKU ASANTE; ABDULLA, Salim; SALIM, Nahya et al.Lancet. Infectious diseases (print). 2011, Vol 11, Num 10, pp 741-749, issn 1473-3099, 9 p.Article